While controlled trials with SRIs have demonstrated a selective efficacy in obsessive-compulsive disorder (OCD), up to 40 -60% of patients do not have a satisfactory outcome. Non-response to treatment in OCD is associated with serious social disability. There are a large number of nonresponsive patients, and they are difficult to cluster due to ambiguities in diagnostic criteria, possibility of subtypes and a high rate of comorbidity. Moreover, the findings of current studies of ''so-called'' non-responsive cases are currently non-generalizable because of the lack of an operational definition of non-response. The result has been that a cumulative body of data on a reasonably homogeneous sample of non-responders has not been developed. The aims of the research in this area are to clarify some of the obstacles in defining stages of response and levels of non-response and, through a comprehensive analysis, to propose a systematic nosology for this rather common condition. Better characterization of which patients respond and do not respond to various treatments will enable more accurate clustering of patients, and help facilitate multisite data collection for future research trials. The authors reviewed also the more recent therapeutic pharmacological and psychological lines for the treatment of refractoriness in OCD. D
While controlled trials with SRIs have demonstrated a selective efficacy in obsessive-compulsive disorder (OCD), up to 40 -60% of patients do not have a satisfactory outcome (CMI, 1991; Goodman et al., 1992; Jenike and Rauch, 1994; McDougle et al., 1993a,b; Piccinelli et al., 1995; Pigott and Seay, 1999; Rasmussen et al., 1993) and these patients have significant disability and morbidity (Hollander et al., 1996) . Since there is no operational definition for the concept of ''non-response'', the labels ''non-responder'', ''treatment-resistant'' and ''treatmentrefractory'' are often used idiosyncratically and synonymously, and all of these terms lack established content validity.
Notwithstanding the lack of precise definitions of response and non-response, several different ''next-step'' therapeutic strategies and even more complex treatment algorithms have been proposed (Dominguez and Mestre, 1994; Dominguez, 1992; Goodman et al., 1993; Pallanti et al., 2004; Jefferson et al., 1995; Jenike, 1992; March et al., 1997; Rasmussen and Eisen, 1997; Rasmussen et al., 1993 ). An evidence-based medicine approach would recommend that clinicians integrate their individual clinical expertise with the best available evidence from systematic research (Guyatt et al., 1993 (Guyatt et al., , 1994 (Guyatt et al., , 1999 . A clear definition and limits of the different clinical phases of the disorder represent a basic requirement to trace any therapeutic algorithm. However, in OCD treatment studies, the lack of operational criteria for non-response has prevented the development of a cumulative body of data on a reasonably homogeneous sample of ''non-responsive'' patients, which has Abbreviations: CBT, cognitive behavioral therapy; CGI, clinical global impression; HQRL, health related quality of life; MAOI, monoamine oxidase inhibitor; NSRI, norepinephrine, serotonin reuptake inhibitor; OCD, obsessivecompulsive disorder; PANDAS, pediatric autoimmune neuropsychiatric disorder associated with streptococcal; SRI, serotonin reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; Y-BOCS, Yale-Brown ObsessiveCompulsive Scale.
